Benzinga | Jul 29, 2020 05:03PM EDT

Taro Pharmaceutical Indus Q1 EPS $(11.37) Down From $1.72 YoY, Sales $117.63M Miss $158.35M Estimate

Taro Pharmaceutical Indus (NYSE:TARO) reported quarterly losses of $(11.37) per share. This is a 761.05 percent decrease over earnings of $1.72 per share from the same period last year. The company reported quarterly sales of $117.63 million which missed the analyst consensus estimate of $158.35 million by 25.71 percent. This is a 27.07 percent decrease over sales of $161.30 million the same period last year.